Reply to comment on “Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders”
- 30 November 2003
- journal article
- other
- Published by Elsevier in European Journal Of Cancer
- Vol. 39 (17) , 2567-2568
- https://doi.org/10.1016/j.ejca.2003.08.019
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological respondersEuropean Journal Of Cancer, 2003
- Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.Journal of Clinical Oncology, 1992